• As a study participant, will I have knowledge of the study medication that I am taking?

    The majority of studies are "double-blinded." This means that neither the study patient nor the principal investigator has knowledge of the drug that the patient has been assigned to during the study. This assures objective interaction on the part of the research staff and the study participant.

  • What if I experience side effects that I feel are associated with the study medication?

    If you feel your are having problems with study medication, you should contact the research office and speak with the study coordinator who has been assigned to you during the study. If a clinician feels you may be experiencing problems with the study medication, it may need to be discontinued.

  • What happens if I have a medical problem after hours or over the weekend?

    The research facility has a phone recording after hours that will instruct study patients how to contact the on call coordinator. There are back up personnel in the event that the coordinator in not able to be reached.

  • Will I receive payment for participation in the study?

    Most studies will reimburse study participants for time. All study related procedures such as physical exam, diagnostic laboratory studies and study medication are free to study participants.

  • What are the risks associated with participation in a study?

    A study patient before any participation in the study signs an informed consent. This "informed consent" will describe any known side effects and risks associated with study medication in addition to outlining any other procedures that will be required during the course of the study.

  • What is required of an individual if they choose to enter into a study?

    Patients involved in clinical drug trials are monitored closely and therefore evaluated frequently. In the early phases of a study, visits are more frequent perhaps once a month, however as the study progresses and the patient is doing well visits become less frequent. Laboratory studies and Electrocardiograms are usually required. Study diaries capture information on side effects, outside office visits and medication changes and need to be maintained throughout the study. Thus, study participants need to be motivated to complete the diary.

  • How longs are study visits?

    The initial visit usually is the longest. This visit may be 1 to 2 hours. It is at this visit; informed consent is reviewed with the patient along with an extensive medical history, physical exam, laboratory studies and other diagnostic tests. Subsequent visits are usually 20 to 30 minutes.

 

Back to top